Drupal.behaviors.print = function(context) {window.print();window.close();}>

Rosetta Inks Commercialization Deal for miRNA Tests with Genetic Technologies

October 22, 2009

Rosetta Inks Commercialization Deal for miRNA Tests with Genetic Technologies

Under the arrangement, Genetic Technologies will hold the market rights to the three tests in Australia, New Zealand, and Singapore.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories